MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder
- PMID: 19004414
- DOI: 10.1080/02791072.2008.10400637
MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder
Abstract
The purpose of this study was to investigate the safety of different doses of MDMA-assisted psychotherapy administered in a psychotherapeutic setting to women with chronic PTSD secondary to a sexual assault, and also to obtain preliminary data regarding efficacy. Although this study was originally planned to include 29 subjects, political pressures led to the closing of the study before it could be finished, at which time only six subjects had been treated. Preliminary results from those six subjects are presented here. We found that low doses of MDMA (between 50 and 75 mg) were both psychologically and physiologically safe for all the subjects. Future studies in larger samples and using larger doses are needed in order to further clarify the safety and efficacy of MDMA in the clinical setting in subjects with PTSD.
Similar articles
-
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.J Psychopharmacol. 2018 Dec;32(12):1295-1307. doi: 10.1177/0269881118806297. Epub 2018 Oct 29. J Psychopharmacol. 2018. PMID: 30371148 Free PMC article. Clinical Trial.
-
A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. Epub 2012 Oct 31. J Psychopharmacol. 2013. PMID: 23118021 Clinical Trial.
-
[MDMA-assisted therapy for PTSD].Laeknabladid. 2024 May;110(5):254-261. doi: 10.17992/lbl.2024.05.793. Laeknabladid. 2024. PMID: 38713560 Review. Icelandic.
-
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.Lancet Psychiatry. 2018 Jun;5(6):486-497. doi: 10.1016/S2215-0366(18)30135-4. Epub 2018 May 1. Lancet Psychiatry. 2018. PMID: 29728331 Clinical Trial.
-
A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.J Psychopharmacol. 2021 May;35(5):501-511. doi: 10.1177/0269881120965915. Epub 2020 Dec 20. J Psychopharmacol. 2021. PMID: 33345689
Cited by
-
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?J Psychopharmacol. 2016 Dec;30(12):1248-1258. doi: 10.1177/0269881116663120. Epub 2016 Aug 25. J Psychopharmacol. 2016. PMID: 27562198 Free PMC article. Review.
-
MDMA and memory, addiction, and depression: dose-effect analysis.Psychopharmacology (Berl). 2022 Mar;239(3):935-949. doi: 10.1007/s00213-022-06086-9. Epub 2022 Feb 18. Psychopharmacology (Berl). 2022. PMID: 35179622 Free PMC article.
-
A Systematic Review of Evidence-Based Treatments for Adolescent and Adult Sexual Assault Victims.J Am Psychiatr Nurses Assoc. 2024 May-Jun;30(3):480-502. doi: 10.1177/10783903231216138. Epub 2023 Dec 26. J Am Psychiatr Nurses Assoc. 2024. PMID: 38148646 Free PMC article.
-
Clinical applications of hallucinogens: A review.Exp Clin Psychopharmacol. 2016 Aug;24(4):229-68. doi: 10.1037/pha0000084. Exp Clin Psychopharmacol. 2016. PMID: 27454674 Free PMC article. Review.
-
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Brain. 2010 Jun;133(Pt 6):1779-97. doi: 10.1093/brain/awq103. Epub 2010 May 17. Brain. 2010. PMID: 20483717 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical